The improvement in efficiency of blood use within a hospital is a major responsibility of the hospital blood bank. Such an improvement can be brought about by introducing a group and antibody screen system or by limiting the amount of blood routinely cross-matched for any procedure. Data to justify this can be best provided with the use of a blood bank microcomputer. Although autologous blood transfusion is the ideal it is difficult to implement in many situations and so homologous blood is used. The use of red cell concentrates in elective surgery has not been shown to be inferior to whole blood in most procedures.
Australia 2 has indicated that much of the blood crossmatched for elective surgery is not used. This over-ordering leads to an increase in the age of blood being transfused and ultimately to wastage by outdating. Various approaches have been taken to improve the situation. In general they have been aimed at reducing the amount of time a unit of blood spends in a cross matched status. The less time a unit of blood spends in such status, the greater will be its availability for ultimate transfusion and the less chance it will be outdated or transfused near the end of its shelf-life.
One method which has been used is to limit the amount of blood ordered for any particular procedure. This has been entitled "the maximum surgical blood order schedule" (MSBOS).3 This reduces excessive preoperative ordering and is undertaken by agreement with the surgical and anaesthetic staff. It has been the experience in hospitals introducing this scheme that senior surgeons were surprised by the number of units of blood being ordered by junior staff. The introduction of an MSBOS requires the co-operation of the clinical staff and their confidence in the ability of the transfusion service to provide blood components readily in emergencies.
Another approach has been called "the group and screen" (G&S).4,5 In this system, surgical procedures are identified which do not usually require blood transfusion. In these procedures, blood is no longer crossmatched but rather the blood group is determined and a careful antibody screen is carried out. If an atypical antibody is found, then antigennegative blood is crossmatched. If no antibodies are found, then the serum is stored at -20 DC. If transfusion is required, during surgery, then "signed" blood is released after an immediate saline spin and ABO group check and the crossmatch is performed retrospectively.
The need for a crossmatch in any blood transfusion was recently discussed in an international forum.6 There was no general agreement about this, but many contributors felt that a sensitive antibody screening procedure was adequate and could replace the antiglobulin phase of the crossmatch. However, the screening phase should be carried out using three screening cells, chosen to represent all major red cell antigens in homozygous form whenever possible. Most participants who use group and screen reported a very satisfactory level of safety. One group from Paris reported that they had been transfusing blood after antibody screening alone for over 30 years with only two cases of reactions linked to anti-private antibOdies.
The G&S system has been applied in many large hospitals in the United States, Europe and in some Australian hospitals. Boral and Henry4 reported the system to be 99.99010 effective. They calculated that if a G&S were performed rather than preoperative crossmatch, the saving to the patient would be 83%, and the laboratory saving would be at least 40%. Flinders Medical Centre has introduced the system for selected procedures together with a firm recommendation for maximum blood ordering. 7 This resulted in a fall of 17% in the number of units crossmatched and 15% in the proportion of outdated blood. They calculated the saving to a 350-bed general hospital at $80,000 per year in 1979.
The experience at St. Vincent's with G&S has been similar. 8 It was introduced for 11 elective procedures and the results analysed over a 12-month period. The overall crossmatch to transfused (CT) ratio for the procedures fell from 11.1 to 3.3 and the mean monthly CT ratio in the hospital fell from 2.7 to 2.2 (p<O.OOl). Blood wastage by expiry fell from 12% to 5% (p<0.02). The mean age of blood being transfused improved from 12.3 days to 10.4 days (p<O.OOl). Since then, the system has continued with no clinical problems and has been fully accepted by the hospital staff. The mean annual CT ratio for these 11 procedures in 1981 and 1982 was 2.8 and 2.2 respectively. The overall transfusion efficiency in the hospital has continued to improve in the succeeding two years ( Table 1 ). In that time, the number of units transfused has peaked while the number of units crossmatched has fallen. This has led to a significant fall in the CT ratio. Furthermore, the blood wastage in the hospital has also improved and is currently 0.6% of blood ordered. A recent survey of blood movements in the hospital revealed the mean length of time a unit of blood spent in a hospital blood bank was 2.2 days, the mean age of blood arriving to the hospital blood bank was 5.1 days and the mean age of blood being transfused was 7.3 days. These improvements were statistically significant ( Table 2) . The blood transfusion request form and the despatch slip containing donor information provide most of the data collected in a hospital blood bank. Several immediate benefits can be realised when this information is stored in a computer. These benefits include ease of storing, retrieval and processing of data.
Our hospital blood bank uses an Apple 1I* microcomputer coupled with a large capacity storage disk drive (Corvus t hard disk, 10 Mbytes).9 All programs are written in BASIC and have been developed in the laboratory itself. The Patient-Master-File (PMF) was created to store the patient's personal, medical and transfusion records. A total of 21,000 patient records can be stored and in our hospital, servicing over 500 beds, the current allocation is sufficient for over four years of use. The PMF program can support data entry, search and update. Access to the data is enhanced by creating an index to the PMF, i.e. the Name-Index and the In-Patient-Number-Index (IP Index). In addition, the program caters for direct PMF access given the record number of the PMF. This access is faster than the search by surname or hospital number since both of these indexes are bypassed.
The donor unit information is stored in the Bottle-File (BF). A total of 12,000 records are allocated for the BF and this is sufficient to store 12 months of donor unit information. The BF is self-indexed to enhance the speed of access and this is done by making the physical location of the record dependent on the unit number. The BF program can support data entry, search and update. In the design of the BF program, special emphasis was placed on "user friendliness" such as "error trapping" and "repeat" features. These features reduce transcription errors by reducing boredom and by keeping the keystrokes to a minimum.
The Patient-Transfusion-File (PTF) was created to draw inferences from the PMF and the BF. The PTF is a composite file containing the PTF-Master and the Blood-Transfused Record-Master (BTR-MASTER) file. Each master file is supported by the corresponding index file, i.e. the PTF-Index and the BTR-Index. A total of 800 and 1000 records are allocated to the PTF-Master and the BTR-Master respectively. Some of the information contained in a PTF Master record includes patient's surname, laboratory number, date of service, number of units crossmatched and transfused, and a reference to the PMF which identifies the patient uniquely. When the patient is transfused, details of the transfused unit, i.e. unit number, blood group and date of transfusion, are recorded in the BTR-Master. Both master files are cross-linked by internal references.
A distinct portion of the Corvus hard disk is allocated to the PTF and this allows the storage of one month's transfusion information. The completed monthly PTF then remains on the hard disk for 12 months. This gives on-line access to transfusion information for 12 months. The PTF program supports data entry, search and update. In the search mode, the user can either reference a record by the surname or unit number. When a particular BTR-Master is found, the linked PTF-Master is also displayed, and vice versa.
The blood bank data base produced by the above program is used to provide the following functions: 1. Archives of individual files (hard copy); 2. Reports on monthly total blood use for the hospital; 3. Reports on monthly blood use on individual procedures or groups of procedures; 4. Reports on individual patient transfusion histories; 5. Quarterly reports on donor units in terms of blood groups, type of package and age on arrival. In summary the microcomputer has helped clinicians monitor and compare the blood needs of their patients, and the blood bank to improve the efficiency of its work.
WHICH BLOOD PRODUCT TO TRANSFUSE

(a) Autologous blood
Autologous blood is the safest form of transfusion. Despite abundant evidence to support this, autologous transfusion has not been widely used for elective surgery. 10 This is partly because of the wide and easier availability of homologous blood. However, recent concerns in the community about the transmission of disease by blood transfusion may induce patients to ask for autologous transfusion, where medical staff have not provided it in the past. A further benefit is a cost saving of approximately Aust.$70 per twounit transfusion. 11 We believe that this form of transfusion is the ideal one and should be encouraged if medically possible in routine surgery. Other techniques which are used include perioperative haemodilution and transfusion and intraoperative scavenging.
(b) Homologous blood
Many anaesthetists and surgeons feel strongly about the use of whole blood rather than red cell concentrates for transfusion in elective surgery. Despite the proven efficacy of component therapy, whole blood remains popular for acute blood loss. Recent evidence has confirmed that red cell concentrates are safe and effective in even major surgery. One study in patients undergoing major aortic reconstruction compared the use of whole blood or packed cells. 12 There was no difference in the increase in the cardiac index or in the postoperative prolongation of clotting studies between the groups. There was a significant decrease in postoperative colloid osmotic pressure in the patients receiving packed cells, but this did not result in any physiological or clinical evidence of significant pulmonary dysfunction. The authors concluded that the study supported the safety of blood replacement with packed cells.
A second study by Hogman et al. 13 investigated the use of red cell concentrates or whole blood or red cells stored in a new medium. They found in patients undergoing various types of orthopaedic surgery that the pattern of bleeding or the amount of blood loss did not vary between these three groups. They concluded that haemotherapy with red cell concentrates or red cells suspended in artificial media was useful and effective in elective surgery and saved plasma for other purposes.
The use of packed red cells in our hospital increased from 63.3070 in 1981 to 93.3% in 1982. A retrospective study of the blood use in some elective surgical procedures during the last two years indicated that the pattern of bleeding was not altered by the increased use of packed red cells (Table 3) . These results were consistent with those obtained by Hogman et al. CONCLUSION Improvement in the efficiency of blood use is a major responsibility of the hospital blood bank and the clinical transfusionist. Any improvement, however, has to be made with the patient's interest at heart. With the aid of a microcomputer the task of processing transfusion data is made easier. This can lead to improvement in the flow of information back to the doctor administering transfusions. Because of the rapid turnover of junior medical staff in hospitals, there is a need for continual update of transfusion statistics and the microcomputer can provide this.
Although autologous transfusion is the ideal, an increase in its use will increase the cost to the hospital and require some increase in staff. This may be difficult in the present economic climate.
The use of red cell concentrates in elective surgery has been shown in several institutions to have no ill effect. We believe that in the majority of cases, the use of whole blood is no longer justified. The wider use of red cell concentrates will release more plasma for use in those patients who really need it.
